Literature DB >> 16906464

The challenge of treating forensic dual diagnosis clients: comment on "integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders".

Robert E Drake1, Joseph P Morrissey, Kim T Mueser.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16906464     DOI： 10.1007/s10597-006-9045-8

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN： 0010-3853


× No keyword cloud information.
  20 in total

1.  Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders.

Authors:  Susan M Essock; Kim T Mueser; Robert E Drake; Nancy H Covell; Gregory J McHugo; Linda K Frisman; Nina J Kontos; Carlos T Jackson; Flora Townsend; Karin Swain
Journal:  Psychiatr Serv       Date:  2006-02       Impact factor: 3.084

2.  Medicaid enrollment and mental health service use following release of jail detainees with severe mental illness.

Authors:  Joseph P Morrissey; Henry J Steadman; Kathleen M Dalton; Alison Cuellar; Paul Stiles; Gary S Cuddeback
Journal:  Psychiatr Serv       Date:  2006-06       Impact factor: 3.084

3.  Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach.

Authors:  Haiyi Xie; Robert Drake; Gregory McHugo
Journal:  Adm Policy Ment Health       Date:  2006-07

4.  A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence.

Authors:  Roger D Weiss; Margaret L Griffin; Monika E Kolodziej; Shelly F Greenfield; Lisa M Najavits; Dennis C Daley; Heidi Ray Doreau; John A Hennen
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

5.  Measuring hospital use without claims: a comparison of patient and provider reports.

Authors:  R E Clark; S K Ricketts; G J McHugo
Journal:  Health Serv Res       Date:  1996-06       Impact factor: 3.402

6.  Forensic assertive community treatment: preventing incarceration of adults with severe mental illness.

Authors:  J Steven Lamberti; Robert Weisman; Dara I Faden
Journal:  Psychiatr Serv       Date:  2004-11       Impact factor: 3.084

Review 7.  The effects of clozapine on aggression and substance abuse in schizophrenic patients.

Authors:  J Volavka
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

Review 8.  Models of community care for severe mental illness: a review of research on case management.

Authors:  K T Mueser; G R Bond; R E Drake; S G Resnick
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

9.  A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Authors:  Alan S Bellack; Melanie E Bennett; Jean S Gearon; Clayton H Brown; Ye Yang
Journal:  Arch Gen Psychiatry       Date:  2006-04

10.  Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders.

Authors:  Robert E Drake; Gregory J McHugo; Haiyi Xie; Melinda Fox; Joan Packard; Barbara Helmstetter
Journal:  Schizophr Bull       Date:  2006-03-08       Impact factor: 9.306
View more
  3 in total

Review 1.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

2.  Diagnostic profiles of offenders in substance abuse treatment programs.

Authors:  Christine E Grella; Lisa Greenwell; Michael Prendergast; Stanley Sacks; Gerald Melnick
Journal:  Behav Sci Law       Date:  2008

3.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Carrie Brooke-Sumner; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.